Forte Biosciences (FBRX) Enterprise Value (2016 - 2020)
Historic Enterprise Value for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to -$20.2 million.
- Forte Biosciences' Enterprise Value rose 2103.21% to -$20.2 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$20.2 million, marking a year-over-year increase of 2103.21%. This contributed to the annual value of -$6.9 million for FY2019, which is 8299.81% up from last year.
- As of Q3 2020, Forte Biosciences' Enterprise Value stood at -$20.2 million, which was up 2103.21% from -$27.7 million recorded in Q2 2020.
- In the past 5 years, Forte Biosciences' Enterprise Value ranged from a high of -$4.1 million in Q3 2016 and a low of -$76.1 million during Q2 2017
- Moreover, its 5-year median value for Enterprise Value was -$20.2 million (2020), whereas its average is -$24.5 million.
- In the last 5 years, Forte Biosciences' Enterprise Value tumbled by 173077.3% in 2017 and then soared by 8299.81% in 2019.
- Forte Biosciences' Enterprise Value (Quarter) stood at -$5.5 million in 2016, then plummeted by 552.14% to -$35.9 million in 2017, then decreased by 13.58% to -$40.8 million in 2018, then soared by 83.0% to -$6.9 million in 2019, then plummeted by 191.11% to -$20.2 million in 2020.
- Its last three reported values are -$20.2 million in Q3 2020, -$27.7 million for Q2 2020, and -$14.2 million during Q1 2020.